Executive Leadership Team
Jorgen B. Hansen
Jorgen B. Hansen is the President and Chief Executive Officer, and a member of the Board of Directors for Cantel. Mr. Hansen joined Cantel in 2012 as Executive Vice President (EVP) and Chief Operations Officer (COO) and was appointed to President and COO in November 2014. He also served as President of Cantel’s Endoscopy Business Unit from November 2012 to July 2015.
Prior to joining Cantel, Mr. Hansen held global leadership positions with increasing responsibility within the global medical device industry for more than 20 years. He worked at ConvaTec from May 2009 - November 2012, most recently as Senior Vice President, Global Marketing, Business Development, Science and Innovation. Mr. Hansen joined ConvaTec from Coloplast, where he held various leadership roles over a 13-year period in Asia and Europe, ranging from General Manager, Division Head and Senior Vice President of Global Operations.
Mr. Hansen received his Bachelor of Science Degree in Mechanical Engineering from Denmark Technical University, and an International Commerce degree from the Copenhagen Business School in Denmark.
Dave Hemink is the President of the Endoscopy Business Unit for Cantel. Mr. Hemink is responsible for day-to-day operations, long term strategic direction, product development, market assessment, acquisition identification and execution, and overall P&L management.
Prior to Cantel, Mr. Hemink was Senior Vice President & President at Boston Scientific Corporation where he led the Electrophysiology business. Prior to Boston Scientific, he spent 10 years with C.R. Bard in a variety of senior leadership roles. Mr. Hemink spent his first six years in Bard Electrophysiology in commercial roles leading Sales and Marketing before moving into General Management. In 2010, he was promoted to President of Bard Access. Prior to C.R. Bard, he was with Abbott Vascular Devices and with Boston Scientific – Microvasive Endoscopy.
Mr. Hemink received his Master’s in Business Administration from Northwestern University - Kellogg School of Management, and his Bachelor of the Arts in Communications from California State University at Fresno.
Curt Weitnauer is the President and CEO of the Cantel Water Filtration and Purification Business Unit for Cantel. In this role, he is responsible for day-to-day operations of the Water Purification and Filtration Business as well as the Renal Business Unit. Mr. Weitnauer is responsible for long-term strategic direction, product development, market assessment, acquisition identification and execution, and overall P&L management.
Prior to joining Cantel, Mr. Weitnauer served as General Manager of the Process Water Group of General Electric (GE) Water Technologies where he led Operations at the GE Osmonics, GE Ionics, and GE Glegg facilities. He was previously Vice President of the Process Water Group of Osmonics, which was acquired by GE in 2003.
Mr. Weitnauer earned a Bachelor of Sciences degree in Chemical Engineering from the University of Minnesota, Institute of Technology. He currently serves on the Board of Directors of Fluid Equipment Development Company, (FEDCO), Salud Spirits and the Minnesota National Kidney Foundation.
Gary Steinberg is President and Chief Executive Officer (CEO) of the Healthcare Disposables Business Unit for Cantel. He is responsible for all facets of the business including strategic planning, mergers and acquisitions, organizational structure, succession planning and the overall financial performance of the business unit.
Mr. Steinberg began his 30 year dental career in 1984 as General Manager of the Frank Allen Dental Lab. In 1990, he joined Crosstex, a Cantel Medical Company, as Vice President of Finance and Operations. Since that time, Mr. Steinberg held numerous leadership positions within the company, each with increasing levels of responsibilities. In 2011, he became the President and CEO.
Mr. Steinberg holds a Bachelor of Science degree in Business Administration with a concentration in Finance from Boston University. He has served on the DTA (Dental Trade Alliance) and the DTAF (Dental Trade Alliance Foundation) Board of Directors, in addition to the Boards other companies, which are indirectly related to the dental industry.
Mike Spicer is President Americas Sales, United Kingdom (UK) and Global Service for Cantel. In this role, he is responsible for Endoscopy sales in the United States as well as overseeing Canadian, Latin American and UK entities of Cantel. Prior to his current role, he served as Senior Vice President, Sales and Service of the Endoscopy Business Unit.
Prior to joining Cantel, Mr. Spicer held various positions with increasing responsibility for more than 24 years, such as Vice President of Sales at Smith & Nephew, within the Advanced Surgical Devices Division. He also was Regional Manager within Boston Scientific and District Sales Manager within Frito-Lay.
Mr. Spicer earned a Bachelor in Business Administration and Business Management from Middle Tennessee State University.
David Rosen is President, Continental Europe, Middle East and Asia-Pacific for Cantel. In this role, he is responsible for the sales and service operations in the direct markets for the Endoscopy Business Unit in The Netherlands, Belgium, Germany, France and Italy in Europe and China, Hong Kong, Singapore and Malaysia in Asia. He is also responsible for the distributor markets though the Cantel offices in The Netherlands, Dubai and Singapore for all business units.
Mr. Rosen has 19 years of global experience in the medical industry. He spent 10 years with Getinge Group, developing their businesses in Europe and Asia-Pacific in both established and emerging markets. Mr. Rosen has a successful track record in setting up direct sales and service teams and multiple distribution channels around the world.
Mr. Rosen earned a Master of Science Degree in Economics from the University of Gothenburg, School of Business, Economics and Law in Sweden and studies in Business Information Management Systems at the University of Plymouth in the United Kingdom.
Craig B. Smith
Craig B. Smith is Senior Vice President, Global Regulatory Affairs and Quality Assurance for Cantel. Mr. Smith joined Cantel in 1997 as Vice President of the Endoscopy Business Unit, responsible for Regulatory Affairs, Quality Assurance and Operations.
Prior to joining the Cantel, Mr. Smith worked in leadership roles with increasing responsibility in Manufacturing Engineering, Regulatory Affairs, Quality Assurance and Operations at B. Braun Medical and Orthomet.
Craig attended the University of Minnesota and Dunwoody College of Technology in Minneapolis and is an active member of the Regulatory Affairs Professional Society (RAPS), Medical Alley and AdvaMed.
Lawrence Conway is the Vice President of Information Systems and Procurement for Cantel. In this role, he is responsible for the IT and Procurement functions as well as post-acquisition integration.
Prior to joining Cantel, Mr. Conway worked at ConvaTec, where we was Vice President and General Manager Ostomy Care. He also played an instrumental role in the divestiture of the company from Bristol-Myers Squibb. Prior to that, Mr. Conway worked as a Management Consultant at several firms including McKinsey & Company and Andersen Consulting.
Mr. Conway holds a Master of Business Administration and Bachelor of Science (Hons) degree from the University of Cape Town.
Peter Clifford is the Executive Vice President and Chief Financial Officer for Cantel. In this role, he is responsible for all financial reporting, financial planning & analysis, auditing, treasury, strategic planning and management, and investor relations.
Prior to joining the Cantel, Mr. Clifford had more than twenty years’ experience in the manufacturing and industrial industry. He served as Vice President of Operations, Finance and Information Technology of IDEX Corporation for six years. For more than half a decade prior to joining IDEX, Mr. Clifford held various senior financial positions for General Electric, ranging from Finance Manager – Appliance Controls/Motion Systems to Financial Planning & Analysis Manager – America’s Consumer & Industrial.
Mr. Clifford received his Bachelor of Science degree in Accounting from Eastern Illinois University, a Masters of Business Administration from Northern Illinois University and is a Senior Executive Program (SEP) graduate from Stanford University Graduate School of Business.
Seth Yellin is Executive Vice President, Strategy and Corporate Development for Cantel. In his role, he oversees Cantel’s corporate strategy and acquisitions. In collaboration with divisional and executive leadership, Mr. Yellin develops overall corporate strategy, identifies potential acquisitions, negotiates and executes transactions, and plans for the integration of these new businesses into the existing Cantel operations.
Prior to joining Cantel, Mr. Yellin spent 10 years working on Wall Street as both an investor and advisor. Most recently, he was an analyst at Citadel Asset Management, focusing on the medical device and life science tools industries. Mr. Yellin began his career at UBS as a mergers and acquisitions (M&A) investment banker, executing transactions in the medical device, healthcare services, and biotechnology sectors.
Mr. Yellin received his undergraduate degree from Princeton University, and a Master of Business Administration degree from The Wharton School at the University of Pennsylvania.
Paul E. Helms
Paul Helms is Executive Vice President of Cantel’s Endoscopy Business Unit for Cantel. In this role he is responsible for global manufacturing operations. Mr. Helms joined the company in 1996 as Senior Vice President of Operations.
Prior to joining Cantel, Mr. Helms worked in progressive roles of executive leadership at Johnson & Johnson and Cabot Medical. His career has focused on Quality Assurance, Engineering and Manufacturing Operations.
Mr. Helms earned a Bachelor of Science degree in Business from Rider University and a Master of Science degree from Rutgers University where he majored in Industrial Engineering. Mr. Helms is an Institute of Industrial Engineers Certified Lean Black Belt.
Eric Nodiff is Executive Vice President, General Counsel and Secretary for Cantel. In this role, Mr. Nodiff leads the legal function for general corporate matters, mergers and acquisitions (M&A), corporate governance and Securities and Exchange Commission (SEC) compliance and is responsible for oversight and supervision of all other legal matters impacting the Company. In addition, Mr. Nodiff serves as a member of the Office of the Chairman. Prior to his current role, he served as Senior Vice President and General Counsel from 2005 to 2014 and also served as Secretary since January 2009.
Prior to joining Cantel, Mr. Nodiff was a partner at the New York City-based law firm Dornbush Schaeffer Strongin & Venaglia, LLP where he practiced primarily in the areas of general corporate law and M&A, representing both public and private companies.
Mr. Nodiff earned a Juris Doctor degree from Hofstra Law School. He is the Founder and President of The Giving Circle of Lower Westchester, a not-for-profit company assisting front-line hunger relief organizations such as food pantries and soup kitchens.
Chris Geschickter is the Vice President of Human Resources (HR) for Cantel. In this role, he is responsible for global strategic planning, policies, practices, direction and daily operations of the HR department.
Prior to joining Cantel, Mr. Geschickter held a number of HR roles of increasing scope and responsibility at NeoStem, Merck, Schering-Plough, Organon and Bristol-Myers Squibb.
Mr. Geschickter received his Bachelor of Arts degree in Psychology at The College of William and Mary and is a Certified Compensation Professional (CCP). He serves on the Board of Directors for the Employers Association of New Jersey.
Milicent Brooks is the Director of Corporate Communications for Cantel. In this role, she is responsible for Cantel’s global internal and external communications strategies, executive communications, media relations and branding.
Prior to Cantel, Ms. Brooks held a number of Communications roles of increasing scope and responsibility for approximately 20 years. Most recently, she was the Global Head of the Cough/Cold/Respiratory Franchise Communications at Novartis. Prior to Novartis, Milicent held public affairs and corporate communications management positions for Pfizer and Ogilvy Commonhealth.
Ms. Brooks holds a Bachelor of Arts in English Communications from Fairleigh Dickinson University.